HeartBeam Future Growth
Future criteria checks 2/6
HeartBeam is forecast to grow earnings and revenue by 48.4% and 62.8% per annum respectively while EPS is expected to grow by 23% per annum.
Key information
48.4%
Earnings growth rate
23.0%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 62.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 16 Nov 2024 |
Recent future growth updates
Recent updates
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation
Sep 19
Companies Like HeartBeam (NASDAQ:BEAT) Could Be Quite Risky
Jan 17HeartBeam gets a new chief medical officer
Oct 11HeartBeam gets patent to enable generation of its credit card-sized ECG, shares rise ~15%
Sep 28HeartBeam surges 54% on U.S. patent for ECG patch monitor to detect heart attacks
Sep 15HeartBeam GAAP EPS of $0.43 beats by $0.70
Aug 11HeartBeam: Cardiovascular Diagnostics On The Go
Dec 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 12 | -10 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -19 | N/A | N/A | 2 |
| 9/30/2024 | N/A | -18 | -13 | -13 | N/A |
| 6/30/2024 | N/A | -17 | -12 | -12 | N/A |
| 3/31/2024 | N/A | -15 | -13 | -12 | N/A |
| 12/31/2023 | N/A | -15 | -12 | -12 | N/A |
| 9/30/2023 | N/A | -14 | -12 | -12 | N/A |
| 6/30/2023 | N/A | -15 | -13 | -13 | N/A |
| 3/31/2023 | N/A | -15 | -11 | -11 | N/A |
| 12/31/2022 | N/A | -13 | -10 | -10 | N/A |
| 9/30/2022 | N/A | -11 | -9 | -9 | N/A |
| 6/30/2022 | N/A | -9 | -7 | -7 | N/A |
| 3/31/2022 | N/A | -6 | -5 | -5 | N/A |
| 12/31/2021 | N/A | -4 | -3 | -3 | N/A |
| 9/30/2021 | N/A | -3 | -1 | -1 | N/A |
| 6/30/2021 | N/A | -2 | -1 | -1 | N/A |
| 3/31/2021 | N/A | -1 | -1 | -1 | N/A |
| 12/31/2020 | N/A | -1 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BEAT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BEAT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BEAT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BEAT's revenue (62.8% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: BEAT's revenue (62.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BEAT's Return on Equity is forecast to be high in 3 years time